Canada · Delayed Price · Currency is CAD Hydreight Technologies Statistics
Total Valuation
TSXV:NURS has a market cap or net worth of CAD 208.22 million. The enterprise value is 201.34 million.
| Market Cap | 208.22M |
| Enterprise Value | 201.34M |
Important Dates
The last earnings date was Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NURS has 53.39 million shares outstanding. The number of shares has increased by 19.71% in one year.
| Current Share Class | 53.39M |
| Shares Outstanding | 53.39M |
| Shares Change (YoY) | +19.71% |
| Shares Change (QoQ) | +8.68% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 1.07% |
| Float | 27.06M |
Valuation Ratios
The trailing PE ratio is 104.36 and the forward PE ratio is 13.00.
| PE Ratio | 104.36 |
| Forward PE | 13.00 |
| PS Ratio | 5.88 |
| PB Ratio | 10.57 |
| P/TBV Ratio | 12.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 108.80, with an EV/FCF ratio of -107.72.
| EV / Earnings | 118.84 |
| EV / Sales | 5.69 |
| EV / EBITDA | 108.80 |
| EV / EBIT | 144.04 |
| EV / FCF | -107.72 |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.45.
| Current Ratio | 3.98 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 4.75 |
| Debt / FCF | -4.69 |
| Interest Coverage | 2.38 |
Financial Efficiency
Return on equity (ROE) is 18.90% and return on invested capital (ROIC) is 6.33%.
| Return on Equity (ROE) | 18.90% |
| Return on Assets (ROA) | 4.73% |
| Return on Invested Capital (ROIC) | 6.33% |
| Return on Capital Employed (ROCE) | 4.89% |
| Weighted Average Cost of Capital (WACC) | 7.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.92 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -580,337 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +132.14% in the last 52 weeks. The beta is 0.53, so TSXV:NURS's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +132.14% |
| 50-Day Moving Average | 3.42 |
| 200-Day Moving Average | 3.88 |
| Relative Strength Index (RSI) | 51.25 |
| Average Volume (20 Days) | 132,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NURS had revenue of CAD 35.39 million and earned 1.69 million in profits. Earnings per share was 0.04.
| Revenue | 35.39M |
| Gross Profit | 9.00M |
| Operating Income | 1.39M |
| Pretax Income | 1.11M |
| Net Income | 1.69M |
| EBITDA | 1.85M |
| EBIT | 1.39M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 15.65 million in cash and 8.77 million in debt, with a net cash position of 6.88 million or 0.13 per share.
| Cash & Cash Equivalents | 15.65M |
| Total Debt | 8.77M |
| Net Cash | 6.88M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 19.70M |
| Book Value Per Share | 0.40 |
| Working Capital | 15.69M |
Cash Flow
In the last 12 months, operating cash flow was -1.87 million and capital expenditures -2,902, giving a free cash flow of -1.87 million.
| Operating Cash Flow | -1.87M |
| Capital Expenditures | -2,902 |
| Depreciation & Amortization | 452,772 |
| Net Borrowing | 10.12M |
| Free Cash Flow | -1.87M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 25.44%, with operating and profit margins of 3.94% and 4.79%.
| Gross Margin | 25.44% |
| Operating Margin | 3.94% |
| Pretax Margin | 3.15% |
| Profit Margin | 4.79% |
| EBITDA Margin | 5.22% |
| EBIT Margin | 3.94% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NURS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.71% |
| Shareholder Yield | -19.71% |
| Earnings Yield | 0.81% |
| FCF Yield | -0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1546061 |
Scores
TSXV:NURS has an Altman Z-Score of 6.83 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.83 |
| Piotroski F-Score | 3 |